Possible association between rhabdomyolysis and mRNA SARS-CoV-2 vaccination in a patient with RYR1 gene mutation
- PMID: 35193861
- PMCID: PMC8863193
- DOI: 10.1503/cmaj.211856
Possible association between rhabdomyolysis and mRNA SARS-CoV-2 vaccination in a patient with RYR1 gene mutation
Conflict of interest statement
Competing interests: Mark Tarnopolsky reports speaker fees from the American College of Sports Medicine and Haroon Yousuf reports a teaching honorarium from Touchstone Institute, outside the submitted work. No other competing interests were declared.
Figures
Comment in
-
Succinylcholine, malignant hyperthermia and rhabdomyolysis.CMAJ. 2022 Jun 27;194(25):E878. doi: 10.1503/cmaj.146480-l. CMAJ. 2022. PMID: 35760427 Free PMC article. No abstract available.
References
-
- Zutt R, van der Kooi AJ, Linthorst GE, et al. . Rhabdomyolysis: review of the literature. Neuromuscul Disord 2014;24:651–9. - PubMed
-
- LiverTox: Clinical and research information on drug-induced liver injury. In: Dantrolene. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012; updated 2017 Jan. 30. Available: https://www.ncbi.nlm.nih.gov/books/NBK548144/ (accessed 2021 Jan. 7). - PubMed
-
- Kateon H. Differentiating serotonin syndrome and neuroleptic malignant syndrome. Ment Health Clin 2013;3:129–33.
-
- Vaccine Adverse Event Reporting System. Atlanta: Centers for Disease Control and Prevention; Silver Spring (MD): US Food and Drug Administration. Available: https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.... (accessed 2021 Jan. 14).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous